gptkbp:instanceOf
|
gptkb:drug
immune response
|
gptkbp:administeredAfter
|
abortion
childbirth
amniocentesis
|
gptkbp:administeredBy
|
Rh-negative individuals
|
gptkbp:administeredDuring
|
pregnancy
|
gptkbp:ATCCode
|
gptkb:J06BB01
|
gptkbp:contraindication
|
hypersensitivity to human immunoglobulins
|
gptkbp:developedBy
|
1960s
|
gptkbp:discoveredBy
|
gptkb:John_G._Gorman
gptkb:Vincent_J._Freda
gptkb:William_Pollack
|
https://www.w3.org/2000/01/rdf-schema#label
|
Rho(D) immune globulin
|
gptkbp:includedIn
|
gptkb:World_Health_Organization's_List_of_Essential_Medicines
|
gptkbp:legalStatus
|
prescription only
|
gptkbp:mechanismOfAction
|
binds RhD antigen on fetal red blood cells
|
gptkbp:otherName
|
gptkb:Anti-D_immunoglobulin
gptkb:BayRho-D
gptkb:Rhogam
gptkb:WinRho
|
gptkbp:pregnancyCategory
|
C (US)
|
gptkbp:prevention
|
maternal sensitization to RhD antigen
|
gptkbp:producedBy
|
human plasma
|
gptkbp:routeOfAdministration
|
intramuscular
intravenous
|
gptkbp:sideEffect
|
fever
injection site reaction
allergic reaction
|
gptkbp:usedFor
|
treatment of immune thrombocytopenic purpura
prevention of Rh isoimmunization
|
gptkbp:bfsParent
|
gptkb:Rh_factor
gptkb:WinRho_SDF
|
gptkbp:bfsLayer
|
7
|